Yong Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yong Liang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Guang Chen
Zhejiang Key Laboratory of New Drug Development for Central Nervous System Diseases, School of Medicine, Taizhou University, Taizhou 318000, China
3 shared publications Jie Chen
Department of Experimental and Clinical Medicine School of Medicine Taizhou University Taizhou China
3 shared publicationsHuai-Lu Ma
Institute of Tumor, Taizhou University, School of Medicine, Taizhou University, Taizhou, Zhejiang, 318000, China
2 shared publicationsSheng-Jian Yu
Institute of Tumor, Taizhou University, School of Medicine, Taizhou University, Taizhou, Zhejiang, 318000, China
2 shared publicationsXiao-Fei Ding
Department of Experimental and Clinical Medicine, School of Medicine, Taizhou University, Taizhou, Zhejiang, 318000, China
2 shared publications- A.S.M. Hung
Schools of Biomedical Sciences and Chinese Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong
1 shared publication
Latest Publications
- Open Access
- 16 August 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1400811
Development and applications of graduate outcome-based curriculum for basic medical education
Introduction: Outcome-based education (OBE) leads to revolutionary change in medical education, but each medical school is acknowledged to develop suited framework based on specific positioning, educational philosophy and expected outcomes.Methods: Based on the graduate outcomes of basic medical education in China released by Working Committee for the Accreditation of Medical Education (WCAME) which officially recognized by World Federation for Medical Education (WFME), Taizhou University re-documented the overall organization of the curriculum and classified the courses as “Crucial, Supporting and Associated (CSA)” categories to connect the graduate outcomes and course objectives.Results: We redefined the standard for graduates in Taizhou University Medical School including 34 items in four domains and redesigned the curriculum with 76 courses classified as CSA. Empirical data reveals a substantial improvement in students’ performance on Standardized Competence Test for Clinical Medicine Undergraduates in China (SCTCMU) by implementing the CSA system between 2022 and 2023. Notably, in 2023, Taizhou University’s students achieved pass rates more than 20 percentage points higher than the national average, demonstrating a profound and unprecedented impact.Conclusion: The CSA classification system provides a notably clear and structured framework for categorizing courses based on their direct or indirect relevance to educational objectives, which provides clarity to educators and empowers students with a more purposeful approach to their studies.
- 16 August 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1400811
Open AccessDevelopment and applications of graduate outcome-based curriculum for basic medical education
Introduction: Outcome-based education (OBE) leads to revolutionary change in medical education, but each medical school is acknowledged to develop suited framework based on specific positioning, educational philosophy and expected outcomes.Methods: Based on the graduate outcomes of basic medical education in China released by Working Committee for the Accreditation of Medical Education (WCAME) which officially recognized by World Federation for Medical Education (WFME), Taizhou University re-documented the overall organization of the curriculum and classified the courses as “Crucial, Supporting and Associated (CSA)” categories to connect the graduate outcomes and course objectives.Results: We redefined the standard for graduates in Taizhou University Medical School including 34 items in four domains and redesigned the curriculum with 76 courses classified as CSA. Empirical data reveals a substantial improvement in students’ performance on Standardized Competence Test for Clinical Medicine Undergraduates in China (SCTCMU) by implementing the CSA system between 2022 and 2023. Notably, in 2023, Taizhou University’s students achieved pass rates more than 20 percentage points higher than the national average, demonstrating a profound and unprecedented impact.Conclusion: The CSA classification system provides a notably clear and structured framework for categorizing courses based on their direct or indirect relevance to educational objectives, which provides clarity to educators and empowers students with a more purposeful approach to their studies.
- Open Access
- 4 February 2021
- Published by Wiley in Cancer Science
- Vol. 112 (4) , 1624-1632
LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β
Lysophosphatidic acid receptor 5 (LPAR5) is involved in mediating thyroid cancer progression, but the underlying mechanism needs to be further revealed. In this study, we confirmed that LPAR5 is upregulated in papillary thyroid carcinoma (PTC) especially in BRAF‐like PTC by analyzing TCGA database and performing immunohistochemistry assay in human thyroid cancer tissues. LPAR5 specific antagonist TC LPA5 4 treatment inhibited CGTH‐W3, TPC‐1, B‐CPAP and BHT‐101 cells proliferation, CGTH‐W3 and TPC‐1 cells migration significantly. In vivo, TC LPA5 4 treatment could delay CGTH‐W3 xenograft growth in nude mice. We also found that LPAR5 specific antagonists TC LPA5 4, PI3K inhibitor Wortmannin or mTOR inhibitor Rapamycin pretreatment abrogated phosphorylation of Akt and p70S6K1 stimulated by LPA in CGTH‐W3 and TPC‐1 cells. Stimulating CGTH‐W3 cells transfected with pEGFPC1‐Grp1‐PH fusion protein with LPA resulted in the generation of phosphatidylinositol (3,4,5)‐triphosphate, which indicates that PI3K was activated by LPA directly. The p110β‐siRNA instead of p110α‐siRNA transfection abrogated the increase of levels of phosphorylated Akt and S6K1 stimulated by LPA. Furthermore, immunoprecipitation assay confirmed an interaction between LPAR5 and p110β. Overall, we provide new insights that the downregulation of LPAR5 decreased the proliferation and migration phenotype via the PI3K/Akt pathway. Inhibition of LPAR5 or PI3K/Akt signal may be the novel therapeutic strategy for treating thyroid cancer.
- 4 February 2021
- Published by Wiley in Cancer Science
- Vol. 112 (4) , 1624-1632
Open AccessLPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β
Lysophosphatidic acid receptor 5 (LPAR5) is involved in mediating thyroid cancer progression, but the underlying mechanism needs to be further revealed. In this study, we confirmed that LPAR5 is upregulated in papillary thyroid carcinoma (PTC) especially in BRAF‐like PTC by analyzing TCGA database and performing immunohistochemistry assay in human thyroid cancer tissues. LPAR5 specific antagonist TC LPA5 4 treatment inhibited CGTH‐W3, TPC‐1, B‐CPAP and BHT‐101 cells proliferation, CGTH‐W3 and TPC‐1 cells migration significantly. In vivo, TC LPA5 4 treatment could delay CGTH‐W3 xenograft growth in nude mice. We also found that LPAR5 specific antagonists TC LPA5 4, PI3K inhibitor Wortmannin or mTOR inhibitor Rapamycin pretreatment abrogated phosphorylation of Akt and p70S6K1 stimulated by LPA in CGTH‐W3 and TPC‐1 cells. Stimulating CGTH‐W3 cells transfected with pEGFPC1‐Grp1‐PH fusion protein with LPA resulted in the generation of phosphatidylinositol (3,4,5)‐triphosphate, which indicates that PI3K was activated by LPA directly. The p110β‐siRNA instead of p110α‐siRNA transfection abrogated the increase of levels of phosphorylated Akt and S6K1 stimulated by LPA. Furthermore, immunoprecipitation assay confirmed an interaction between LPAR5 and p110β. Overall, we provide new insights that the downregulation of LPAR5 decreased the proliferation and migration phenotype via the PI3K/Akt pathway. Inhibition of LPAR5 or PI3K/Akt signal may be the novel therapeutic strategy for treating thyroid cancer.
- Open Access
- 1 December 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 132, 110821
Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway
- 1 December 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 132, 110821
Open AccessSodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway
- Open Access
- 1 January 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 121, 109578
CA8 promotes RCC proliferation and migration though its expression level is lower in tumor compared to adjacent normal tissue
- 1 January 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 121, 109578
Open AccessCA8 promotes RCC proliferation and migration though its expression level is lower in tumor compared to adjacent normal tissue
- 1 May 2016
- Published by Elsevier in Progress in Histochemistry and Cytochemistry
- Vol. 51 (1) , 1-8
Mutated tau, amyloid and neuroinflammation in Alzheimer disease—A brief review
- 1 May 2016
- Published by Elsevier in Progress in Histochemistry and Cytochemistry
- Vol. 51 (1) , 1-8
Mutated tau, amyloid and neuroinflammation in Alzheimer disease—A brief review
- Open Access
- 1 December 2015
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 30
Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma
The aim of this study was to detect the expression of hypoxia-inducible factor (HIF)-1α and HIF-2α in papillary thyroid carcinoma (PTC) compared with normal thyroid tissues. The mRNA levels and protein levels of HIF-1α and HIF-2α were detected by real-time PCR and Western blot separately in 30 pairs of PTCs and normal thyroid cases. The protein levels were also detected by immunohistochemistry (IHC) using 92 samples of PTC group and 46 normal samples as control group for analyzing the biological and clinical significance of the expression of HIF-1α/HIF-2α. Real-time PCR results showed the mRNA level of HIF-1α and HIF-2α were significantly higher in PTC than normal group (P < 0.001). Also, significantly higher positive rates (73 %/65 %) of HIF-1α and HIF-2α were observed in PTC compared with the control group (27 %/35 %) by IHC (P < 0.01); the consistent results were gotten with Western blot. Although we did not find a significant correlation between the expression of HIF-1α and HIF-2α with gender, age, calcification, or Hashimoto’s disease in the present study (P > 0.05), both of their expressions were correlated to lymph node metastasis (P < 0.05), capsular invasion (P < 0.05), and TNM stage (P < 0.05). Overexpression of HIF-1α and HIF-2α are associated with the carcinogenesis of PTC, served as potential biomarkers of PTC.
- 1 December 2015
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 30
Open AccessExpression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma
The aim of this study was to detect the expression of hypoxia-inducible factor (HIF)-1α and HIF-2α in papillary thyroid carcinoma (PTC) compared with normal thyroid tissues. The mRNA levels and protein levels of HIF-1α and HIF-2α were detected by real-time PCR and Western blot separately in 30 pairs of PTCs and normal thyroid cases. The protein levels were also detected by immunohistochemistry (IHC) using 92 samples of PTC group and 46 normal samples as control group for analyzing the biological and clinical significance of the expression of HIF-1α/HIF-2α. Real-time PCR results showed the mRNA level of HIF-1α and HIF-2α were significantly higher in PTC than normal group (P < 0.001). Also, significantly higher positive rates (73 %/65 %) of HIF-1α and HIF-2α were observed in PTC compared with the control group (27 %/35 %) by IHC (P < 0.01); the consistent results were gotten with Western blot. Although we did not find a significant correlation between the expression of HIF-1α and HIF-2α with gender, age, calcification, or Hashimoto’s disease in the present study (P > 0.05), both of their expressions were correlated to lymph node metastasis (P < 0.05), capsular invasion (P < 0.05), and TNM stage (P < 0.05). Overexpression of HIF-1α and HIF-2α are associated with the carcinogenesis of PTC, served as potential biomarkers of PTC.
- 30 June 2015
- Published by Spandidos Publications in Oncology Reports
- Vol. 34 (3) , 1424-1430
PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications
- 30 June 2015
- Published by Spandidos Publications in Oncology Reports
- Vol. 34 (3) , 1424-1430
PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications